Arbutus Biopharma Corporation (ABUS)
NASDAQ · Healthcare
Arbutus Biopharma Corporation Cash on Hand 2011–2025
Arbutus Biopharma Corporation annual cash on hand history from 2013 to 2025. Cash on hand refers to the total amount of cash and cash equivalents held by a company.
- Arbutus Biopharma Corporation cash on hand as of December 31, 2025: 18.0M, a 50.43% decrease year-over-year.
- Arbutus Biopharma Corporation cash on hand for 2025 were 18.0M, a 50.43% decrease from 2024.
- Arbutus Biopharma Corporation cash on hand for 2024 were 36.3M, a 38.22% increase from 2023.
- Arbutus Biopharma Corporation cash on hand for 2023 were 26.3M, a 14.59% decrease from 2022.
- Arbutus Biopharma Corporation cash on hand for 2022 were 30.8M.
Cash on Hand
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Arbutus Biopharma Corporation Annual Cash on Hand (Millions of US $) | |
|---|---|
| 2025 | $18 |
| 2024 | $36 |
| 2023 | $26 |
| 2022 | $31 |
| 2021 | $109 |
| 2020 | $52 |
| 2019 | $32 |
| 2018 | $37 |
| 2017 | $54 |
| 2016 | $23 |
| 2015 | $167 |
| 2014 | $72 |
| 2013 | $69 |
Arbutus Biopharma Corporation Cash on Hand — FAQ
Arbutus Biopharma Corporation (ABUS) cash on hand over the last 15 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see ABUS's cash on hand history?
The chart and table above show Arbutus Biopharma Corporation's cash on hand by year and by quarter, including the growth rate.